We have performed a comprehensive proteomic analysis of the core histones from CD19+ B cells from healthy individuals and the malignant counterpart in CLL patient samples as well as from bladder and breast cancer cell line models. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.